Список литературы

1. Centers for Disease Control and Prevention. Sexually Transmitted diseases treatment guidelines (2015).

2. European guideline for the management of pelvic inflammatory disease (2017). Jonathan Rossi, Secondo Guaschino, Marco Cusini and Jorgen Jensen.

3. The British Association for Sexual Health and HIV (BASHH). Pelvic inflammatory disease. Guideline. 2019.

4. Национальное руководство гинекология. под руководством Савельевой Г.М., Сухих Г.Т., Серова В.Н., Радзинского В.Е., Манухина И.Б. 2017.

5. Краснопольский В.И., Буянова С.Н., Щукина Н.А. Гнойная гинекология. Руководство. Москва. Медпресс. 2001. С. 288.

6. Diagnosis and management of tubo ovarian abscesses. Kirsty Munro, Asma Gharaibeh, Sangeetha Nagabushanam, Cameron Martin. Royal College of Obstetricians and Gynaecologists. Review. 2018. P. 11 - 19.

7. Canadian Guidelines on Sexually Transmitted Infections - Management and treatment of specific syndromes - Pelvic Inflammatory Disease (PID). 2016.

8. De Carvalho N.S., Palu G., Witkin S.S. Mycoplasma genitalium, a stealth female reproductive tract. Eur J Clin Microbiol Infect Dis. 2019 Sep. 14. doi: 10.1007/s10096-019-03707-8.

9. Tamarelle J., Thiebaut ACM, de Barbeyrac B., Bebear C., Ravel J., Delarocque-Astagneau E. The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis. Clin Microbiol Infect. 2019 Jan; 25(1): 35 - 47.

10. Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials. Ricardo F. Savaris, Daniele G. Fuhrich, Rui V. Duarte, Sebastian Franik, Jonathan D.C. Ross. Sex Transm Infect. 2019 Feb; 95(1): 21 - 27.

11. Lee N.C., Rubin G.L., Grimes D.A. Measures of sexual behavior and the risk of pelvic inflammatory disease. Obstet Gynecol 1991; 77: 425.

12. Kapustian V., Namazov A., Yaakov O., Volodarsky M., Anteby E.Y., Gemer O. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study. Arch Gynecol Obstet. 2018 May; 297(5): 1201 - 1204.

13. Интернет ресурс www.mkb-10.com.

14. Серов В.В., Пауков В.С. Воспаление руководство для врачей - М.: Медицина, 1995. - 639 с.

15. Ha M.M., Belcher HME, Butz A.M., Perin J., Matson P.A., Trent M. Partner Notification, Treatment, and Subsequent Condom Use After Pelvic Inflammatory Disease: Implications for Dyadic Intervention With Urban Youth. Clin Pediatr (Phila) 2019 Oct; 58(11-12): 1271 - 1276.

16. Savaris R.F., Fuhrich D.G., Duarte R.V., Franik S., Ross JDC. Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials. Sex Transm Infect. 2019; 95(1): 21 - 27. doi: 10.1136/sextrans-2018-053693.

17. Australian Sexual Health Alliance (ASHA). Australian management guidline. Pelvic inflammatory disease. 2018.

18. Erenel H., Yilmaz N., Oncul M., Acikgoz A.S., Karatas S., Ayhan I., Aslan B., Tuten A. Usefulness of Serum Procalcitonin Levels in Predicting Tubo-Ovarian Abscess in Patients with Acute Pelvic Inflammatory Disease. Gynecol Obstet Invest. 2017; 82(3): 262 - 266. doi: 10.1159/000449161. Epub 2016 Sep. 3. PMID: 27592364.

19. Pelvic Inflammatory Disease Management Guidelines. 2017. The New Zealand Sexual Health Society.

20. Lis R., Rowhani-Rahbar A., Manhart L.E. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015 Aug 1; 61(3): 418-26. doi: 10.1093/cid/civ312. Epub 2015 Apr. 21. PMID: 25900174.

21. Price M.J., Ades A.E., De Angelis D., Welton N.J., Macleod J., Soldan K., Simms I., Turner K., Horner P.J. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013 Aug 1; 178(3): 484-92. doi: 10.1093/aje/kws583. Epub 2013 Jun 27. PMID: 23813703; PMCID: PMC3727337.;

22. Low N., Bender N., Nartey L., Shang A., Stephenson J.M. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol. 2009 Apr; 38(2): 435-48. doi: 10.1093/ije/dyn222. Epub 2008 Dec 5. PMID: 19060033.;

23. McGee Z.A., Jensen R.L., Clemens C.M., Taylor-Robinson D., Johnson A.P., Gregg C.R. Gonococcal infection of human fallopian tube mucosa in organ culture: relationship of mucosal tissue TNF-alpha concentration to sloughing of ciliated cells. Sex Transm Dis. 1999 Mar; 26(3): 160-5. doi: 10.1097/00007435-199903000-00007. PMID: 10100774.

24. Munson E., Bykowski H., Munson K.L., et al. Clinical laboratory assessment of Mycoplasma genitalium transcription-mediated amplification using primary female urogenital specimens. J Clin Microbiol 2016; 54: 432-8.;

25. Tan L. Clinical and diagnostic challenge of antimicrobial resistance in Mycoplasma genitalium. MLO Med Lab Obs 2017; 2017: 8 - 12.].

26. Miller J.M., Binnicker M.J., Campbell S., Carroll K.C., Chapin K.C., Gilligan P.H., Gonzalez M.D., Jerris R.C., Kehl S.C., Patel R., Pritt B.S., Richter S.S., Robinson-Dunn B., Schwartzman J.D., Snyder J.W., Telford S. 3rd, Theel E.S., Thomson R.B. Jr., Weinstein M.P., Yao J.D. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31; 67(6): e1 - e94. doi: 10.1093/cid/ciy381. PMID: 29955859; PMCID: PMC7108105.

27. Patel M.D., Young S.W., Dahiya N. Ultrasound of Pelvic Pain in the Nonpregnant Woman. Radiol Clin North Am. 2019 May; 57(3): 601 - 616.

28. Clinical Effectiveness Group. UK national guideline for the management of pelvic inflammatory disease 2011. London (UK): British Association for Sexual Health and HIV; 2011 Jun. 18 p. [39 references].

29. Xiao G., Xiao X. Sepsis-Induced Lung Injury: The Mechanism and Treatment // Severe Trauma and Sepsis. - Springer, Singapore, 2019. - С. 253 - 275.

30. Kulchavenya E., Naber K.G., Johansen T.E.B. Urogenital tuberculosis // Extrapulmonary Tuberculosis. - Springer, Cham, 2019. - С. 141 - 153.

31. Sartelli M., Weber D.G., Rupp E., Bassetti M., Wright B.J., Ansaloni L. et all. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016 Jul 15; 11: 33. doi: 10.1186/s13017-016-0089-y. e Collection 2016.

32. Программа СКАТ (Стратегия Контроля Антимикробной Терапии) при оказании стационарной медицинской помощи: Российские клинические рекомендации/Под ред. С.В. Яковлева, Н.И. Брико, С.В. Сидоренко, Д.Н. Проценко. - М.: Издательство "Перо", 2018. - 156 с.

33. Mathur M., Scoutt L.M. Nongynecologic Causes of Pelvic Pain: Ultrasound First. Obstet Gynecol Clin North Am. 2019 Dec; 46(4): 733 - 753.

34. Curry A., Williams T., Penny M.L. Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention. Am Fam Physician. 2019 Sep 15; 100(6): 357 - 364.

35. Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике: Евразийские клинические рекомендации/под ред. С.В. Яковлева, С.В. Сидоренко, В.В. Рафальского, Т.В. Спичак. М.: Издательство "Пре100 Принт", 2016, 0 - 144 с.

36. Walker C.K., Wiesenfeld H.C. Antibiotic therapy for acute pelvic inflammatory disease: the 2006 CDC Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 2007; 28 [Supp 1]: S29-36.

37. Овсянникова Т.В., Макаров И.О., Куликов И.А. Предгравидарная подготовка пациенток с воспалительными заболеваниями женских половых органов. Эффективна фармакотерапия. Акушерство и Гинекология. 2013. N 3 (28). С. 10 - 16.

38. Практическое руководство по антиинфекционной химиотерапии/Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. - Смоленск: МАКМАХ, 2007. - 464 с.

39. The effectiveness of nonsteroidal anti-inflammatory agents in the treatment of pelvic inflammatory disease: a systematic review. Divya Dhasmana, Emma Hathorn, Racheal McGrath, Anjum Tariq, Jonathan Dc Ross. 2014 Jul 22; 3: 79. doi: 10.1186/2046-4053-3-79.

40. Non-steroidal anti-inflammatory drugs for low back pain. van Tulder M.W., Scholten R.J., Koes B.W., Deyo R.A.Cochrane Database Syst Rev. 2000; (2): CD000396. doi: 10.1002/14651858.CD000396.

41. Клиническая хирургия: национальное руководство: в 3 т./под ред. В.С. Савельева, А.И. Кириенко. - М.: ГЭОТАР-Медиа, 2010. - Т. III. - 1008 с. - (Серия "Национальные руководства").

42. Магнитотерапия в лечебно-реабилитационных и профилактических программах: клинические рекомендации. - Москва. 2015, 47 с.

43. Лазерная терапия в лечебно-реабилитационных и профилактических программах: клинические рекомендации. - Москва. 2015, 68 с.

44. Клинические рекомендации, основанные на доказательствах "Физическая и реабилитационная медицина" Г.Н. Пономаренко, Д.В. Ковлен, Санкт-Петербург, 2018, 38 с.

45. Almeida C.C., Maldaner da Silva VZM, Cipriano Junior G., Liebano R.E., Quagliotti Durigan J.L. Transcutaneous electrical nerve stimulation and interferential current demonstrate similar effects in relieving acute and chronic pain: a systematic review with meta-analysis. Brazilian Journal of Physical Therapy 2018 Sep-Oct; 22(5): 347 - 354.

46. Duarte R., Fuhrich D., Ross J.D. A review of antibiotic therapy for pelvic inflammatory disease. Int J Antimicrob Agents. 2015 Sep; 46(3): 272-7. Epub 2015 Jun 17. PMID: 26126798.

47. K.A. Workowski, S. Berman Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010, MMWR Recomm Rep, 59 (2010), pp. 1 - 110.

48. Woodward C., Fisher M.A. Drug treatment of common STDs: Part II. Vaginal infections, pelvic inflammatory disease and genital warts. Am Fam Physician. 1999 Oct 15; 60(6): 1716-22. PMID: 10537386